These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22801643)

  • 1. Selective non-lipid modulator of LPA5 activity in human platelets.
    Kozian DH; Evers A; Florian P; Wonerow P; Joho S; Nazare M
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5239-43. PubMed ID: 22801643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.
    Williams JR; Khandoga AL; Goyal P; Fells JI; Perygin DH; Siess W; Parrill AL; Tigyi G; Fujiwara Y
    J Biol Chem; 2009 Jun; 284(25):17304-17319. PubMed ID: 19366702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.
    Lee CW; Rivera R; Gardell S; Dubin AE; Chun J
    J Biol Chem; 2006 Aug; 281(33):23589-97. PubMed ID: 16774927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1β release.
    Lundequist A; Boyce JA
    PLoS One; 2011 Mar; 6(3):e18192. PubMed ID: 21464938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between platelets and endothelial progenitor cells via LPA-Edg-2 axis is augmented by PPAR-δ activation.
    Han JK; Kim BK; Won JY; Shin Y; Choi SB; Hwang I; Kang J; Lee HJ; Koh SJ; Lee J; Hur J; Cho HJ; Chae IH; Oh BH; Park YB; Kim HS
    J Mol Cell Cardiol; 2016 Aug; 97():266-77. PubMed ID: 27266389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5.
    Kozian DH; von Haeften E; Joho S; Czechtizky W; Anumala UR; Roux P; Dudda A; Evers A; Nazare M
    Chembiochem; 2016 May; 17(9):861-5. PubMed ID: 26812365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
    Jenkin KA; He P; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
    Sandmann G; Siess W; Essler M
    Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.
    Jiang G; Inoue A; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1865-9. PubMed ID: 23395664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5.
    Wang M; He P; Han Y; Dong L; Yun CC
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):1073-1092. PubMed ID: 33975030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
    Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
    Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
    Hama K; Aoki J
    Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.
    Araki M; Kitayoshi M; Dong Y; Hirane M; Ozaki S; Mori S; Fukushima N; Honoki K; Tsujiuchi T
    Growth Factors; 2014 Jun; 32(3-4):117-22. PubMed ID: 24798396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate.
    Motohashi K; Shibata S; Ozaki Y; Yatomi Y; Igarashi Y
    FEBS Lett; 2000 Feb; 468(2-3):189-93. PubMed ID: 10692584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway.
    Pamuklar Z; Lee JS; Cheng HY; Panchatcharam M; Steinhubl S; Morris AJ; Charnigo R; Smyth SS
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):555-61. PubMed ID: 18202325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline.
    Nilsson U; Svensson SP; Grenegård M
    Haematologica; 2002 Jul; 87(7):730-9; discussion 739. PubMed ID: 12091124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.
    Li G; Mosier PD; Fang X; Zhang Y
    J Mol Graph Model; 2009 Aug; 28(1):70-9. PubMed ID: 19423373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.